首页> 外文OA文献 >539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans

【2h】

539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans

机译：539. GS-CA2：一种新型，有效和选择性和选择性的HIV-1衣壳功能的阶级抑制剂，显示支持人类长效潜力的非纯药代动力学

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jim Zheng; Stephen R Yant; Shekeba Ahmadyar; Tiffany Y Chan; Anna Chiu; Tomas Cihlar; John O Link; Bing Lu; Judy Mwangi; William Rowe; Scott D Schroeder; George J Stepan; Kelly Wei Wang; Raju Subramanian; Winston C Tse;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model [J] . Yant Stephen R., Mulato Andrew, Hansen Derek, Nature medicine . 2019,第9期

机译：一种高效的长效的小分子HIV-1衣壳抑制剂，具有人源化小鼠模型的功效
2. A nonclinical safety and pharmacokinetic evaluation of N6022: A first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma [J] . ColagiovanniD.B., DroletD.W., Langlois-ForgetE., Regulatory Toxicology and Pharmacology: RTP . 2012,第1期

机译：N6022的非临床安全性和药代动力学评估：一流的S-亚硝基谷胱甘肽还原酶抑制剂治疗哮喘
3. Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitor [J] . TirmensteinM., DorrT.E., JanovitzE.B., International journal of toxicology . 2013,第5期

机译：非临床毒理学评估支持dapagliflozin（一种一流的钠-葡萄糖共转运蛋白2抑制剂）的长期安全性
4. Functional evaluation of bacterial surface displayed P domain from human norovirus capsid proteins [C] . Shaofeng Rong, Yue Zhou, Mengya Niu, International Conference on Innovative Material Science and Technology . 2017

机译：细菌表面的功能评估显示来自人诺维病毒衣壳蛋白的P域
5. In search of selective and potent Golgi alpha-mannosidase II inhibitors as potential anticancer agents: Synthesis of 3-substituted-swainsonine analogs and preparation of immobilized swainsonine analogs on solid support. [D] . Guo, Luyi. 2003

机译：寻找选择性和有效的高尔基α-甘露糖苷酶II抑制剂作为潜在的抗癌药：3-取代-swainsonine类似物的合成和在固体支持物上固定的swainsonine类似物的制备。
6. 539. GS-CA2: A Novel Potent and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans [O] . Jim Zheng, Stephen R Yant, Shekeba Ahmadyar, -1

机译：539. GS-CA2：HIV-1衣壳功能的新型有效和选择性一流抑制剂显示了非临床药代动力学可在人类中发挥长效作用
7. Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models [O] . 2014

机译：长效拓扑异构酶1抑制剂依替立替康聚乙二醇（NKTR-102）在多种癌症模型中的非临床药代动力学和活性
8. Chemotherapeutic Potential of G1 Cell Cycle Inhibitor Indole-3-Carbinol and Its More Potent N-Alkoxy Derivatives in Human Breast Cancer Xenografts in Mice [R] . Kerekatte, V. S. , Firestone, G. 2004

机译：G1细胞周期抑制剂吲哚-3-甲醇及其更有效的N-烷氧基衍生物在小鼠人乳腺癌异种移植物中的化疗潜力

539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans

著录项

引文网络

相似文献

相关主题

期刊订阅